These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7278138)

  • 1. Immunological status of maculoanaesthetic leprosy: leucocyte migration inhibition test as a measure of cell mediated immune response.
    Rao SS; Rao PR
    Lepr India; 1981 Jul; 53(3):340-9. PubMed ID: 7278138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S; Mishra RS; Nath I
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
    Mohanty KK; Joshi B; Katoch K; Sengupta U
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNCB contact sensitization in leprosy: its comparison with other CMI tests.
    Jayasingh K; Bhatia VN
    Indian J Lepr; 1984; 56(2):207-11. PubMed ID: 6548491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved leucocyte migration inhibition response of leucocytes from lepromatous leprosy patients with hapten modified M. leprae.
    Fotedar A; Mustafa AS; Narang BS; Talwar GP
    Clin Exp Immunol; 1982 Aug; 49(2):317-24. PubMed ID: 6751637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell mediated immunity in a group of lepers (leukocytes migration inhibition test)].
    García González J; Diáz Almeida J; Mayea Milián L; de la Cruz Castillo F
    Rev Cubana Med Trop; 1978; 30(2):53-8. PubMed ID: 368912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cell-mediated immune responses in erythema nodosum leprosum reactions of leprosy.
    Rao TD; Rao PR
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):36-41. PubMed ID: 3549939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte migration inhibition test in leprosy patients across the spectrum of leprosy.
    Sivamani S; Garg BR; Lal S
    Lepr India; 1980 Oct; 52(4):527-31. PubMed ID: 7464058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological status of maculo-anaesthetic leprosy: T and B lymphocytes and serum immunoglobulins.
    Rao SS; Rao TD; Rao PR
    Lepr India; 1982 Jul; 54(3):471-8. PubMed ID: 6983629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients.
    Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A
    Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum factors affecting the cell migration inhibition response to lepromin.
    Fliess EL; Ruibal-Ares B; Braun M
    Int J Lepr Other Mycobact Dis; 1975; 43(4):320-6. PubMed ID: 1241688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucocyte migration inhibition response of Mycobacterium habana with sensitized animals and cells from leprosy patients.
    Singh NB; Gupta HP; Mathur IS; Kumar A; Chakraborty SK
    Indian J Lepr; 1985; 57(2):273-7. PubMed ID: 3935726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
    Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
    Hamasaki K
    Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of circulating immune complexes of leprosy patients on leukocyte migration inhibition induced by Mycobacterium leprae antigens in healthy volunteers.
    Tyagi P; Girdhar BK; Katoch K; Sengupta V
    Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):487-92. PubMed ID: 1890375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.